首页> 外文OA文献 >A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein

【2h】

A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein

机译：使用CYP2B6 / NADPH-细胞色素P450还原酶融合蛋白肺癌的病毒定向酶前药治疗（VDEPT）策略

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marina Tychopoulos; Laurent Corcos; Philippe Genne; Philippe Beaune; Isabelle de Waziers;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6|[sol]|NADPH-cytochrome P450 reductase fusion protein [J] . Marina Tychopoulos, Laurent Corcos, Philippe Genne, Cancer gene therapy . 2005,第5期

机译：使用CYP2B6 | [sol] | NADPH-细胞色素P450还原酶融合蛋白的病毒指导的肺癌药物前药治疗（VDEPT）策略
2. Dynamic mobility of genetically expressed fusion protein between cytochrome P4501A1 and NADPH-cytochrome P450 reductase in yeast microsomes. [J] . Yamada M, Ohta Y, Sakaki T, Biochemistry . 1999,第29期

机译：酵母微粒体中基因表达的融合蛋白在细胞色素P4501A1和NADPH-细胞色素P450还原酶之间的动态迁移。
3. EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF A CATALYTICALLY ACTIVE HUMAN CYTOCHROME P450 1A2-RAT NADPH-CYTOCHROME P450 REDUCTASE FUSION PROTEIN [J] . Parikh A., Guengerich FP. Protein Expression and Purification . 1997,第3期

机译：具有催化活性的人类细胞色素P450 1A2-大鼠NADPH-细胞色素P450还原酶融合蛋白的表达，纯化和鉴定
4. Thermally Responsive Multivalent Fusion Proteins as TRAILR-2 Superagonists for Cancer Therapy [C] . Mana T. Manzari, Mareva Fevre, Ashutosh Chilkoti PEGS . 2015

机译：热响应性多价融合蛋白作为癌症治疗的铁路-2超谓蛋白
5. Gene dependent enzyme prodrug therapy for head and neck cancer. [D] . Hamstra, Daniel Allan. 2001

机译：基因依赖性酶前药治疗头颈癌。
6. In vitro studies on CNGRC-CPG2 fusion proteins for ligand-directed enzyme prodrug therapy for targeted cancer therapy [O] . Layla Al-mansoori, Sara S. Bashraheel, Alanod D. Al Qahtani, 2020

机译：CNGRC-CPG2融合蛋白在配体指导的酶前药治疗中的靶向性癌症治疗的体外研究
7. Dynamic Mobility of Genetically Expressed Fusion Protein between Cytochrome P4501A1 and NADPH-Cytochrome P450 Reductase in Yeast Microsomes [O] . Suguru Kawato 1999

机译：遗传表达融合蛋白在酵母微粒体中细胞色素p4501a1和NaDpH-细胞色素p450还原酶的动态迁移率
8. Development of a Novel Enzyme/Prodrug Strategy for Gene Therapy of Breast Cancer [R] . Hamstra, D. , Rehemtulla, A. 2000

机译：乳腺癌基因治疗新酶/前药策略的研究进展

A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein

著录项

引文网络

相似文献

相关主题

期刊订阅